Xenon Pharmaceuticals to Present at the 2022 Jefferies Healthcare Conference

Rhea-AI Summary

Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a biopharmaceutical company specializing in neurology, will participate in one-on-one investor meetings and present at the 2022 Jefferies Healthcare Conference from June 8-10, 2022, in New York, NY. Ian Mortimer, President and CEO, will present on June 8 at 2:30 pm Eastern Time. A live webcast will be available on the company’s website, with archived recordings to follow. Xenon focuses on developing therapies for neurological disorders, particularly epilepsy.

BURNABY, British Columbia, June 01, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that management will participate in one-on-one investor meetings and present at the 2022 Jefferies Healthcare Conference to be held June 8-10, 2022 in New York, NY.

Company Presentation Details:

Date: Time: Presenter:

Wednesday, June 8, 2022 2:30 pm Eastern Time Ian Mortimer, President and CEO

A webcast of the company presentation will also be broadcast live on the “Investors” section of Xenon's website at investor.xenon-pharma.com. When available, webcasts will be posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

FAQ

When will Xenon Pharmaceuticals present at the 2022 Jefferies Healthcare Conference?

Xenon Pharmaceuticals will present on June 8, 2022, at 2:30 pm Eastern Time.

Who is the presenter for Xenon Pharmaceuticals at the Jefferies Healthcare Conference?

Ian Mortimer, President and CEO, will present for Xenon Pharmaceuticals.

Where can I watch the webcast of Xenon Pharmaceuticals' presentation?

The webcast will be available on the Investors section of Xenon Pharmaceuticals' website.

What are the dates for the 2022 Jefferies Healthcare Conference?

The 2022 Jefferies Healthcare Conference will be held from June 8-10, 2022.

What is the primary focus of Xenon Pharmaceuticals?

Xenon Pharmaceuticals focuses on developing innovative therapeutics for neurological disorders, particularly epilepsy.